ABUS
Arbutus Biopharma Corp
Company overview
- Market capitalization
- $961.54M
- Employees
- 19
- Latest publication
- 2026-09-29
About Arbutus Biopharma Corp
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,014,000USD | 179,126,000USD | 1,051,000USD | 529,000USD | 10,739,000USD | 1,339,000USD | 1,726,000USD | 1,532,000USD |
| Research Development | 2,898,000USD | 4,120,000USD | 5,006,000USD | 5,778,000USD | 5,498,000USD | 14,273,000USD | 15,551,000USD | 15,403,000USD |
| Selling General Administrative | 3,867,000USD | 5,889,000USD | 3,689,000USD | 3,044,000USD | 3,328,000USD | 4,537,000USD | 7,547,000USD | 5,312,000USD |
| General And Administrative Expenses | 3,867,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 6,978,000USD | 9,998,000USD | 8,684,000USD | 8,811,000USD | 9,251,000USD | 22,779,000USD | 23,309,000USD | 20,895,000USD |
| Operating Income | -5,964,000USD | 169,117,000USD | -7,644,000USD | -8,293,000USD | 1,488,000USD | -21,440,000USD | -21,583,000USD | -19,363,000USD |
| Total Other Income Expense Net | 821,000USD | 578,000USD | 3,888,000USD | 551,000USD | 1,035,000USD | 1,723,000USD | 1,787,000USD | 1,488,000USD |
| Interest Income | 842,000USD | 815,000USD | 877,000USD | 952,000USD | 1,042,000USD | 1,747,000USD | 1,829,000USD | 1,545,000USD |
| Interest Expense | 18,000USD | 17,000USD | 18,000USD | 23,000USD | 28,000USD | 29,000USD | 34,000USD | 44,000USD |
| Net Income | -5,143,000USD | 169,695,000USD | -3,756,000USD | -7,742,000USD | 2,523,000USD | -19,717,000USD | -19,796,000USD | -17,875,000USD |
| Cost Of Revenue | — | 11,000USD | 11,000USD | 11,000USD | 11,000USD | — | 356,000USD | 15,403,000USD |
| Gross Profit | — | 179,115,000USD | 1,040,000USD | 518,000USD | 10,739,000USD | 1,339,000USD | 1,726,000USD | 1,532,000USD |
| Net Interest Income | — | 798,000USD | 859,000USD | 929,000USD | 1,014,000USD | 1,718,000USD | 1,795,000USD | 1,501,000USD |
| Income Before Tax | — | 169,695,000USD | -3,756,000USD | -7,742,000USD | 2,523,000USD | -19,717,000USD | -19,796,000USD | -17,875,000USD |
| Net Income From Continuing Ops | — | 169,695,000USD | -3,756,000USD | -7,742,000USD | 2,523,000USD | -19,717,000USD | -19,796,000USD | -17,875,000USD |
| Ebit | — | 169,712,000USD | -3,738,000USD | -7,719,000USD | 2,551,000USD | -19,688,000USD | -19,762,000USD | -17,831,000USD |
| Ebitda | — | 169,723,000USD | -3,727,000USD | -7,708,000USD | 2,562,000USD | -19,352,000USD | -19,406,000USD | -17,476,000USD |
| Depreciation And Amortization | — | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 336,000USD | 356,000USD | 355,000USD |
| Reconciled Depreciation | — | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 336,000USD | 356,000USD | 355,000USD |
| Selling And Marketing Expenses | — | — | 11,000USD | 11,000USD | — | — | 356,000USD | 355,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | 3,969,000USD | — | — |
| Income Tax Expense | — | — | — | — | — | — | -1USD | -1USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,083,000USD | 6,171,000USD | 18,141,000USD | 39,019,000USD | 5,900,000USD | 10,700,000USD | 1,500,000USD | 24,873,000USD |
| Cost Of Revenue | 363,000USD | 1,380,000USD | 73,700,000USD | 1,427,000USD | 57,900,000USD | 62,700,000USD | 61,300,000USD | 51,505,000USD |
| Gross Profit | 13,720,000USD | 6,171,000USD | 18,141,000USD | 39,019,000USD | -52,000,000USD | -52,000,000USD | -59,800,000USD | -26,632,000USD |
| Research Development | 25,241,000USD | 54,037,000USD | 73,700,000USD | 84,408,000USD | 57,900,000USD | 62,700,000USD | 61,300,000USD | 51,505,000USD |
| Selling General Administrative | 15,893,000USD | 22,108,000USD | 22,475,000USD | 17,834,000USD | 16,000,000USD | 16,100,000USD | 39,400,000USD | 26,438,000USD |
| Total Operating Expenses | 40,771,000USD | 82,490,000USD | 96,244,000USD | 104,475,000USD | 76,100,000USD | 80,800,000USD | 101,800,000USD | 78,532,000USD |
| Operating Income | -27,051,000USD | -76,319,000USD | -78,103,000USD | -65,456,000USD | -89,800,000USD | -110,900,000USD | -491,600,000USD | -102,322,000USD |
| Interest Income | 4,068,000USD | 6,585,000USD | 5,166,000USD | 2,192,000USD | 3,047,000USD | 1,538,000USD | 1,391,000USD | 25,786,000USD |
| Interest Expense | 97,000USD | 137,000USD | 459,000USD | 1,726,000USD | 200,000USD | 261,000USD | 1,391,000USD | 674,000USD |
| Net Interest Income | 3,971,000USD | 6,448,000USD | 4,442,000USD | 466,000USD | 2,821,000USD | 1,277,000USD | 1,391,000USD | — |
| Income Before Tax | -33,501,000USD | -69,920,000USD | -72,849,000USD | -65,012,000USD | -61,400,000USD | -108,700,000USD | -489,100,000USD | -77,306,000USD |
| Net Income | -33,501,000USD | -69,920,000USD | -72,849,000USD | -69,456,000USD | -57,100,000USD | -84,400,000USD | -384,100,000USD | -61,121,000USD |
| Net Income From Continuing Ops | -33,501,000USD | -69,920,000USD | -75,469,000USD | -69,456,000USD | -57,060,000USD | -84,413,000USD | -384,164,000USD | -61,121,000USD |
| Ebit | -33,404,000USD | -69,783,000USD | -72,390,000USD | -63,286,000USD | -61,134,000USD | -108,472,000USD | -489,166,000USD | -77,306,000USD |
| Ebitda | -33,041,000USD | -68,403,000USD | -70,986,000USD | -61,859,000USD | -58,953,000USD | -106,445,000USD | -488,074,000USD | -76,717,000USD |
| Depreciation And Amortization | 363,000USD | 1,380,000USD | 1,404,000USD | 1,427,000USD | 2,181,000USD | 2,027,000USD | 1,092,000USD | 589,000USD |
| Reconciled Depreciation | 363,000USD | 1,380,000USD | 1,352,000USD | 1,427,000USD | 2,181,000USD | 2,027,000USD | — | — |
| Total Other Income Expense Net | -6,450,000USD | 6,399,000USD | 5,254,000USD | 444,000USD | 28,438,000USD | 2,197,000USD | 2,473,000USD | 25,016,000USD |
| Unclassified Operating Expenses | — | 6,345,000USD | — | 2,233,000USD | 2,200,000USD | 2,000,000USD | 1,100,000USD | — |
| Tax Provision | — | 0USD | 0USD | 4,444,000USD | -4,282,000USD | -24,320,000USD | -105,002,000USD | -16,185,000USD |
| Income Tax Expense | — | — | -1USD | 4,444,000USD | -4,300,000USD | -24,300,000USD | -105,000,000USD | -16,185,000USD |
| Non Operating Income Net Other | — | — | — | 2,170,000USD | 28,664,000USD | 2,458,000USD | 2,473,000USD | 25,016,000USD |
| Net Income Applicable To Common Shares | — | — | — | -69,456,000USD | -67,151,000USD | -85,324,000USD | -384,164,000USD | -61,121,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 274,025,000USD | 277,164,000USD | 94,618,000USD | 97,710,000USD | 103,267,000USD | 117,010,000USD | 131,707,000USD | 140,441,000USD |
| Cash And Equivalents | 19,171,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 273,883,000USD | 277,011,000USD | 94,456,000USD | 97,442,000USD | 103,119,000USD | 116,808,000USD | 127,316,000USD | 132,776,999USD |
| Other Current Assets | 1,516,000USD | 180,473,000USD | 1,238,000USD | 2,835,000USD | 4,006,001USD | 2,919,000USD | 2,284,000USD | 3,374,999USD |
| Other Non Current Assets | 132,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 15,292,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,364,000USD | 5,105,000USD | 6,006,000USD | 5,184,000USD | 5,022,000USD | 19,431,000USD | 15,618,000USD | 18,923,000USD |
| Total Stockholder Equity | 258,733,000USD | 260,177,000USD | 76,576,000USD | 77,399,000USD | 82,976,000USD | 79,157,000USD | 97,366,000USD | 106,890,000USD |
| Total Equity Including Noncontrolling Interest | 258,733,000USD | — | — | — | — | — | — | — |
| Net Receivables | 369,000USD | 1,312,000USD | 1,747,000USD | 905,000USD | 1,024,999USD | 1,182,000USD | 2,409,000USD | 1,608,000USD |
| Property Plant Equipment Net | 10,000USD | 22,000USD | 32,000USD | 137,000USD | 148,000USD | 168,000USD | 4,357,000USD | 4,700,000USD |
| Accounts Payable | 373,000USD | 1,462,000USD | 1,173,000USD | 1,011,000USD | 1,321,000USD | 2,240,000USD | 2,316,000USD | 2,315,000USD |
| Short Term Debt | 514,000USD | 631,000USD | 547,000USD | 531,000USD | 514,000USD | 563,000USD | 483,000USD | 468,000USD |
| Common Stock | 1,448,177,000USD | 1,444,494,000USD | 1,421,429,000USD | 1,418,560,000USD | 1,417,110,000USD | 1,416,332,000USD | 1,410,025,000USD | 1,407,595,000USD |
| Retained Earnings | -1,215,521,000USD | -1,210,378,000USD | -1,380,073,000USD | -1,376,317,000USD | -1,368,575,000USD | -1,371,098,000USD | -1,346,572,000USD | -1,334,040,000USD |
| Accumulated Other Comprehensive Income | -48,244,000USD | -48,195,000USD | -48,098,000USD | -48,129,000USD | -48,187,000USD | -48,166,000USD | -48,135,000USD | -48,089,999USD |
| Total Liab | — | 16,987,000USD | 18,042,000USD | 20,311,000USD | 20,291,000USD | 37,853,000USD | 34,341,000USD | 33,551,000USD |
| Other Current Liab | — | 3,012,000USD | 4,286,000USD | 3,642,000USD | 3,187,000USD | 9,869,000USD | 5,248,000USD | 5,229,000USD |
| Capital Stock | — | 1,444,494,000USD | 1,421,429,000USD | 1,418,560,000USD | 1,417,110,000USD | 1,416,332,000USD | 1,410,025,000USD | 1,407,595,000USD |
| Cash | — | 23,706,000USD | 18,008,000USD | 22,408,000USD | 37,412,000USD | 37,076,000USD | 36,330,000USD | 31,846,000USD |
| Cash And Short Term Investments | — | 95,226,000USD | 91,471,000USD | 93,702,000USD | 98,088,000USD | 112,707,000USD | 122,623,000USD | 127,794,000USD |
| Net Debt | — | -19,797,000USD | -13,820,000USD | -17,802,000USD | -32,413,000USD | -31,478,000USD | -30,212,000USD | -25,085,000USD |
| Short Long Term Debt Total | — | 3,909,000USD | 4,188,000USD | 4,606,000USD | 4,999,000USD | 5,598,000USD | 6,118,000USD | 6,761,000USD |
| Short Term Investments | — | 71,520,000USD | 73,463,000USD | 71,294,000USD | 60,676,000USD | 75,631,000USD | 86,293,000USD | 95,948,000USD |
| Property Plant Equipment Gross | — | 246,000USD | 245,000USD | 13,484,000USD | 13,463,000USD | 13,494,000USD | 17,353,000USD | 17,363,000USD |
| Common Stock Shares Outstanding | — | 195,214,067shares | 191,599,600shares | 191,778,950shares | 192,399,733shares | 190,707,085shares | 189,963,492shares | 188,997,194shares |
| Non Current Assets Total | — | 153,000USD | 162,000USD | 268,000USD | 148,000USD | 202,000USD | 4,391,000USD | 7,664,000USD |
| Non Current Liabilities Total | — | 11,882,000USD | 12,036,000USD | 15,127,000USD | 15,269,000USD | 18,422,000USD | 18,723,000USD | 14,628,000USD |
| Non Current Liabilities Other | — | 11,882,000USD | 11,837,000USD | 14,736,000USD | 14,694,000USD | 14,933,000USD | 15,054,000USD | 13,650,000USD |
| Non Currrent Assets Other | — | 131,000USD | 130,000USD | 131,000USD | — | 34,000USD | 34,000USD | 1USD |
| Net Working Capital | — | 271,906,000USD | 88,450,000USD | 92,258,000USD | 98,097,000USD | 97,377,000USD | 111,698,000USD | 113,854,000USD |
| Unclassified Equity | — | -1,370,238,000USD | -1,338,111,000USD | -1,335,275,000USD | -1,334,482,000USD | -1,334,243,000USD | -1,327,977,000USD | -1,326,170,001USD |
| Current Deferred Revenue | — | — | — | — | — | 6,759,000USD | 7,571,000USD | 10,911,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 3,489,000USD | 3,669,000USD | — |
| Long Term Investments | — | — | — | — | — | — | 0USD | 2,964,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 94,618,000USD | 131,707,000USD | 144,401,000USD | 195,419,000USD | 204,485,000USD | 137,080,000USD | 105,535,000USD | 227,905,000USD |
| Other Current Assets | 1,238,000USD | 2,284,000USD | 4,248,000USD | 2,874,000USD | 4,445,000USD | 3,124,000USD | 1,790,000USD | 3,181,000USD |
| Total Liab | 18,042,000USD | 34,341,000USD | 38,383,000USD | 58,567,000USD | 35,046,000USD | 35,114,000USD | 32,791,000USD | 27,671,000USD |
| Total Stockholder Equity | 76,576,000USD | 97,366,000USD | 106,018,000USD | 136,852,000USD | 169,439,000USD | 101,966,000USD | 72,744,000USD | 200,234,000USD |
| Other Current Liab | 4,286,000USD | 5,248,000USD | 7,048,000USD | 12,509,000USD | 7,664,000USD | 6,157,000USD | 5,090,000USD | 8,047,000USD |
| Common Stock | 1,421,429,000USD | 1,410,025,000USD | 1,349,821,000USD | 1,318,737,000USD | 1,286,636,000USD | 985,939,000USD | 898,535,000USD | 879,405,000USD |
| Capital Stock | 1,421,429,000USD | 1,410,025,000USD | 1,349,821,000USD | 1,318,737,000USD | 1,286,636,000USD | 1,135,347,000USD | 1,035,820,000USD | 1,005,541,000USD |
| Retained Earnings | -1,380,073,000USD | -1,346,572,000USD | -1,276,652,000USD | -1,203,803,000USD | -1,134,347,000USD | -1,045,961,000USD | -970,093,000USD | -805,221,000USD |
| Cash | 18,008,000USD | 36,330,000USD | 26,285,000USD | 30,776,000USD | 109,282,000USD | 52,251,000USD | 31,799,000USD | 36,942,000USD |
| Cash And Short Term Investments | 91,471,000USD | 122,623,000USD | 126,003,000USD | 146,913,000USD | 155,317,000USD | 123,268,000USD | 90,834,000USD | 124,617,000USD |
| Total Current Assets | 94,456,000USD | 127,316,000USD | 132,027,000USD | 151,139,000USD | 160,661,000USD | 127,704,000USD | 93,828,000USD | 129,229,000USD |
| Total Current Liabilities | 6,006,000USD | 15,618,000USD | 22,487,000USD | 32,857,000USD | 11,221,000USD | 9,541,000USD | 7,828,000USD | 11,239,000USD |
| Net Debt | -13,820,000USD | -30,212,000USD | -17,564,000USD | -18,224,000USD | -90,372,000USD | -29,714,000USD | -28,441,000USD | -36,942,000USD |
| Short Term Debt | 547,000USD | 483,000USD | 425,000USD | 372,000USD | 383,000USD | 390,000USD | 340,000USD | — |
| Short Long Term Debt Total | 4,188,000USD | 6,118,000USD | 8,721,000USD | 12,552,000USD | 18,910,000USD | 22,537,000USD | 3,358,000USD | — |
| Short Term Investments | 73,463,000USD | 86,293,000USD | 99,718,000USD | 116,137,000USD | 46,035,000USD | 71,017,000USD | 59,035,000USD | 87,675,000USD |
| Net Receivables | 1,747,000USD | 2,409,000USD | 1,776,000USD | 1,352,000USD | 899,000USD | 1,312,000USD | 1,204,000USD | 1,431,000USD |
| Accounts Payable | 1,173,000USD | 2,316,000USD | 3,223,000USD | 3,520,000USD | 3,174,000USD | 2,994,000USD | 2,398,000USD | 3,192,000USD |
| Property Plant Equipment Net | 32,000USD | 4,357,000USD | 6,090,000USD | 6,814,000USD | 8,074,999USD | 9,332,000USD | 11,414,000USD | 10,145,000USD |
| Property Plant Equipment Gross | 245,000USD | 17,353,000USD | 17,990,000USD | 6,814,000USD | 8,075,000USD | 9,332,000USD | 11,414,000USD | 10,145,000USD |
| Accumulated Other Comprehensive Income | -48,098,000USD | -48,135,000USD | -48,421,000USD | -50,488,000USD | -48,334,999USD | -48,170,999USD | -48,229,000USD | -48,170,000USD |
| Common Stock Shares Outstanding | 191,599,600shares | 185,608,874shares | 165,960,379shares | 150,939,337shares | 106,242,452shares | 75,835,378shares | 57,093,454shares | 55,304,083shares |
| Non Current Assets Total | 162,000USD | 4,391,000USD | 12,374,000USD | 44,280,000USD | 43,824,000USD | 9,376,000USD | 11,707,000USD | 98,676,000USD |
| Non Current Liabilities Total | 12,036,000USD | 18,723,000USD | 15,896,000USD | 25,710,000USD | 23,825,000USD | 25,573,000USD | 24,963,000USD | 16,432,000USD |
| Non Current Liabilities Other | 11,837,000USD | 15,054,000USD | 14,553,000USD | 19,711,000USD | 16,296,000USD | 19,554,000USD | 24,963,000USD | 3,126,000USD |
| Non Currrent Assets Other | 130,000USD | 34,000USD | — | 103,000USD | 61,001USD | 44,000USD | 293,000USD | 22,224,000USD |
| Net Working Capital | 88,450,000USD | 111,698,000USD | 109,540,000USD | 118,282,000USD | 149,440,000USD | 118,163,000USD | 86,000,000USD | 117,990,000USD |
| Unclassified Equity | -1,338,111,000USD | -1,327,977,000USD | -1,268,551,000USD | -1,246,331,000USD | -1,221,151,001USD | -925,188,001USD | -843,289,000USD | -831,321,000USD |
| Current Deferred Revenue | — | 7,571,000USD | 11,791,000USD | 16,456,000USD | 7,638,000USD | 5,907,000USD | 4,837,000USD | — |
| Long Term Investments | — | 0USD | 6,284,000USD | 37,363,000USD | 35,688,000USD | 0USD | 0USD | 22,224,000USD |
| Unclassified Non Current Liabilities | — | 3,669,000USD | 1,343,000USD | -17,896,000USD | -14,065,000USD | -16,961,000USD | -21,945,000USD | -16,432,000USD |
| Other Assets | — | — | 1USD | 103,000USD | 61,000USD | 44,000USD | 293,000USD | — |
| Inventory | — | — | -1,776,000USD | -2,874,000USD | -4,445,000USD | -3,124,000USD | — | — |
| Other Liab | — | — | — | 23,895,000USD | 21,594,000USD | 22,980,000USD | 21,945,000USD | 16,432,000USD |
| Net Tangible Assets | — | — | — | 136,852,000USD | 169,439,000USD | -47,442,000USD | -64,541,000USD | 74,098,000USD |
| Unclassified Current Liabilities | — | — | — | — | -7,638,000USD | -5,907,000USD | -4,837,000USD | — |
| Good Will | — | — | — | — | — | — | 0USD | 22,471,000USD |
| Intangible Assets | — | — | — | — | — | — | — | 43,836,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 13,306,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | -22,224,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 169,695,000USD | -3,756,000USD | -7,742,000USD | 2,523,000USD | -24,526,000USD | -12,532,000USD | -19,717,000USD | -19,796,000USD |
| Depreciation | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 330,000USD | 333,000USD | 336,000USD | 356,000USD |
| Stock Based Compensation | 1,359,000USD | 1,262,000USD | 1,263,000USD | 864,000USD | 3,564,000USD | 1,632,000USD | 2,160,000USD | 3,180,000USD |
| Other Non Cash Items | -309,000USD | -3,995,000USD | -499,000USD | -907,000USD | 1,972,000USD | 481,000USD | -1,016,000USD | -1,002,000USD |
| Change To Account Receivables | 1,160,000USD | -129,000USD | 120,000USD | 157,000USD | 1,227,000USD | -801,000USD | 159,000USD | 372,000USD |
| Change In Working Capital | -178,866,000USD | 1,798,000USD | 1,150,000USD | -18,240,000USD | 5,269,000USD | -229,000USD | -2,499,000USD | 2,758,000USD |
| Total Cash From Operating Activities | -8,110,000USD | -4,680,000USD | -5,817,000USD | -15,749,000USD | -13,391,000USD | -10,315,000USD | -20,736,000USD | -14,504,000USD |
| Capital Expenditures | -8,110,000USD | -4USD | -1USD | -1USD | 0USD | -86,000USD | -410USD | -1,000USD |
| Free Cash Flow | -8,110,000USD | -4,680,000USD | -5,817,000USD | -15,749,000USD | -13,391,000USD | -10,401,000USD | -20,736,000USD | -14,505,000USD |
| Investments | 2,200,000USD | -1,716,000USD | -10,019,000USD | 15,611,000USD | 11,349,000USD | 13,411,000USD | -11,986,000USD | 9,829,000USD |
| Total Cashflows From Investing Activities | 2,199,000USD | -1,361,000USD | -10,019,000USD | 15,611,000USD | 11,349,000USD | 13,411,000USD | -11,986,000USD | 9,829,000USD |
| Total Cash From Financing Activities | 11,619,000USD | 1,640,000USD | 844,000USD | 453,000USD | 2,784,000USD | 1,421,000USD | 1,775,000USD | 24,370,000USD |
| Change In Cash | 5,698,000USD | -4,400,000USD | -15,004,000USD | 336,000USD | 746,000USD | 4,484,000USD | -30,942,000USD | 19,687,000USD |
| Begin Period Cash Flow | 18,008,000USD | 22,408,000USD | 37,412,000USD | 37,076,000USD | 36,330,000USD | 31,846,000USD | 62,788,000USD | 43,101,000USD |
| End Period Cash Flow | 23,706,000USD | 18,008,000USD | 22,408,000USD | 37,412,000USD | 37,076,000USD | 36,330,000USD | 31,846,000USD | 62,788,000USD |
| Other Cashflows From Investing Activities | -1,000USD | 355,000USD | 541,000USD | 677,000USD | 718,000USD | -3,333USD | 39,245,008USD | 9,734,000USD |
| Other Cashflows From Financing Activities | 11,619,000USD | 50,650USD | 844,000USD | 453,000USD | 2,784,000USD | 1,422,000USD | 1,775,000USD | 2,011,000USD |
| Unclassified Investing Cash Flow | 8,110,000USD | — | — | — | — | — | -39,244,598USD | -9,733,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | -1,000USD | 0USD | 22,359,000USD |
| Unclassified Financing Cash Flow | — | 1,589,350USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -33,501,000USD | -69,920,000USD | -72,849,000USD | -69,456,000USD | -76,247,000USD | -63,745,000USD | -153,723,000USD | -57,100,000USD |
| Depreciation | 363,000USD | 1,380,000USD | 1,404,000USD | 1,427,000USD | 1,753,000USD | 1,978,000USD | 2,028,000USD | 2,181,000USD |
| Stock Based Compensation | 6,953,000USD | 8,986,000USD | 9,301,000USD | 7,182,000USD | 6,424,000USD | 6,161,000USD | 6,799,000USD | 6,241,000USD |
| Other Non Cash Items | -3,429,000USD | -2,467,000USD | -5,559,000USD | -3,752,000USD | 7,785,000USD | 9,328,000USD | 88,776,000USD | -10,665,000USD |
| Change To Account Receivables | 1,375,000USD | -633,000USD | -424,000USD | -453,000USD | 413,000USD | -108,000USD | 227,000USD | -1,029,000USD |
| Change In Working Capital | -10,023,000USD | -2,829,000USD | -18,233,000USD | 29,243,000USD | 930,000USD | 431,000USD | -2,225,000USD | -4,275,000USD |
| Total Cash From Operating Activities | -39,637,000USD | -64,850,000USD | -85,936,000USD | -35,356,000USD | -67,532,000USD | -51,441,000USD | -71,006,000USD | -67,900,000USD |
| Capital Expenditures | 0USD | -182,000USD | -1,008,000USD | -512,000USD | -809,000USD | -229,000USD | -589,000USD | -1,138,000USD |
| Free Cash Flow | -39,637,000USD | -65,032,000USD | -86,944,000USD | -35,868,000USD | -68,341,000USD | -51,670,000USD | -71,595,000USD | -69,038,000USD |
| Investments | 15,216,000USD | 22,948,000USD | 41,230,000USD | -74,430,000USD | -11,869,000USD | -14,680,000USD | 28,916,000USD | -3,014,000USD |
| Total Cashflows From Investing Activities | 15,580,000USD | 22,948,000USD | 50,773,000USD | -74,942,000USD | -12,678,000USD | -14,909,000USD | 28,338,000USD | -4,100,000USD |
| Total Cash From Financing Activities | 5,721,000USD | 51,996,000USD | 30,647,000USD | 31,814,000USD | 137,236,000USD | 86,746,000USD | 37,457,000USD | 55,600,000USD |
| Issuance Of Capital Stock | 0USD | 44,123,000USD | 26,110,000USD | 20,324,000USD | 134,665,000USD | 86,297,000USD | 18,601,000USD | 66,265,000USD |
| Change In Cash | -18,322,000USD | 10,045,000USD | -4,491,000USD | -78,506,000USD | 57,031,000USD | 20,452,000USD | -5,143,000USD | -17,400,000USD |
| Begin Period Cash Flow | 36,330,000USD | 26,285,000USD | 30,776,000USD | 109,282,000USD | 52,251,000USD | 31,799,000USD | 36,942,000USD | 54,300,000USD |
| End Period Cash Flow | 18,008,000USD | 36,330,000USD | 26,285,000USD | 30,776,000USD | 109,282,000USD | 52,251,000USD | 31,799,000USD | 36,900,000USD |
| Other Cashflows From Investing Activities | -152,564,000USD | 164,639,000USD | 20,000USD | -458,000USD | -12,678,000USD | -12,678,000USD | 11,000USD | -2,962,000USD |
| Other Cashflows From Financing Activities | 5,721,000USD | 7,873,000USD | 795,000USD | 11,490,000USD | 14,710,000USD | 12,572,000USD | 30,005,000USD | 77,738,000USD |
| Unclassified Investing Cash Flow | 152,928,000USD | -164,457,000USD | 10,531,000USD | — | 12,678,000USD | 12,678,000USD | — | 3,014,000USD |
| Change To Inventory | — | — | 6,182,000USD | — | -1,911,000USD | — | — | 762,000USD |
| Unclassified Financing Cash Flow | — | — | 3,742,000USD | 9,351,000USD | -2,571,000USD | — | — | -67,693,000USD |
| Change To Liabilities | — | — | — | 27,266,000USD | 1,542,000USD | 1,291,000USD | -4,058,000USD | 65,000USD |
| Sale Purchase Of Stock | — | — | — | 10,973,000USD | 137,236,000USD | 86,746,000USD | 18,908,000USD | 67,647,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -78,484,000USD | 57,026,000USD | 20,396,000USD | -5,143,000USD | -17,350,000USD |
| Dividends Paid | — | — | — | — | -12,139,000USD | -12,123,000USD | -11,149,000USD | -10,091,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -8,177,000USD | -5,594,000USD | -12,661,000USD | -4,282,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | 68,000USD | -1,003,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -12,001,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration And Contracts | 204,000 | USD | 0001447028-26-000021 |
| Q1 2026Quarterly · 2026-03-31 | Product | License | 178,741,000 | USD | 0001447028-26-000021 |
| Q1 2026Quarterly · 2026-03-31 | Product | Non Cash Royalty | 181,000 | USD | 0001447028-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration And Contracts | 1,316,000 | USD | 0001447028-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | License | 0 | USD | 0001447028-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Non Cash Royalty | 448,000 | USD | 0001447028-26-000021 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.